Report cover image

Pharmaceutical Packaging: United States

Published Jul 01, 2025
Length 22 Pages
SKU # FFO20198009

Description

This report forecasts to 2029 US pharmaceutical packaging demand in nominal US dollars at the manufacturer level. Total demand is segmented by product in terms of: bottles and jars, blister packaging, boxes and cartons, prefillable syringes, parenteral vials and ampuls, and other packaging products such as bulk shipping containers, IV containers, and prefillable inhalers.

To illustrate historical trends, total demand and the various segments are provided in annual series from 2019 to 2024.

Pharmaceutical caps and closures, labels, and packaging accessories are excluded unless otherwise stated. For the purposes of this report, pharmaceutical packaging demand is defined as the value of finished packaging products sold by merchant companies and produced or assembled internally by pharmaceutical manufacturers and contract packaging firms. Bulk packaging is also included in the Other segment.

Demand for blister packaging in this report includes not only the blister component itself but also the value of the secondary folding carton, shrink wrap, and other accessories (such as tamper-evident seals or packaging inserts). In other words, it is the cost of a finished package to the drug maker (whether it is produced internally or by contract packaging firms). The blister component of the package is generally not used on its own without secondary packaging. As such, demand for boxes and cartons used in the blister packaging is excluded from secondary packaging data to avoid double counting.

US statistics for pharmaceutical packaging products include sales and production activities in Puerto Rico. Most major multinational drug makers operate one or more production facilities and consume a significant volume of packaging in that territory.

Key macroeconomic indicators are also provided with quantified trends. Other various topics, including profiles of pertinent leading companies, are covered in this report. A full outline of report items by page is available in the Table of Contents.

Related NAICS Codes:

  • 322130 Paperboard Mills
  • 322211 Corrugated and Solid Fiber Box Manufacturing
  • 322220 Paper Bag and Coated and Treated Paper Manufacturing
  • 326112 Plastics Packaging Film and Sheet (including Laminated) Manufacturing
  • 326160 Plastics Bottle Manufacturing
  • 326199 All Other Plastics Product Manufacturing
  • 327213 Glass Container Manufacturing
  • 331315 Aluminum Sheet, Plate, and Foil Manufacturing
  • 332431 Metal Can Manufacturing

Table of Contents

22 Pages
HIGHLIGHTS
MARKET ENVIRONMENT
Historical Trends
Key Economic Indicators
Environmental & Regulatory Factors
PRODUCT SEGMENTATION & FORECASTS
Bottles & Jars
Blister Packaging
Prefillable Syringes
Parenteral Vials & Ampuls
Boxes & Cartons
Other Packaging
INDUSTRY STRUCTURE
Industry Characteristics
Market Leaders
ABOUT THIS REPORT
Scope
Sources
Industry Codes
Freedonia Methodology
Resources
LIST OF TABLES & FIGURES
Figure 1 | Key Trends in US Pharmaceutical Packaging Demand, 2024 – 2029
Figure 2 | US Pharmaceutical Packaging Demand Trends, 2019 – 2024
Table 1 | Key Indicators for US Pharmaceutical Packaging Demand; 2019, 2024, 2029 (2017 US$ bil)
Figure 3 | US Pharmaceutical Packaging Demand by Product, 2019 – 2029 (US$ bil)
Table 2 | US Pharmaceutical Packaging Demand by Product, 2019 – 2024 (US$ bil)
Table 3 | US Pharmaceutical Packaging Demand by Product, 2024 – 2029 (US$ bil)
Figure 4 | US Pharmaceutical Packaging Demand by Product, 2019 – 2029 (%)
Table 4 | NAICS & SIC Codes Related to Pharmaceutical Packaging

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.